IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
This study has suspended participant recruitment.
Sponsor:
National Institute of Dental and Craniofacial Research (NIDCR)
Collaborators:
National Institute of Neurological Disorders and Stroke (NINDS)
Sorrento Therapeutics, Inc.
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute of Dental and Craniofacial Research (NIDCR) )
ClinicalTrials.gov Identifier:
NCT00804154
First received: December 5, 2008
Last updated: June 30, 2017
Last verified: May 9, 2017
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has suspended participant recruitment. |
|---|---|
| Estimated Study Completion Date: | December 30, 2020 |
| Estimated Primary Completion Date: | June 30, 2020 (Final data collection date for primary outcome measure) |